Q2 2024

Filed Jan 25, 2024 · 10-Q · 56 days after period end · 0001683168-24-000433

Q2 2024 · 10-Q

Revenue

$63.75K

−22.8% vs Q2 2023

Net Income

-$124.43K

N/M vs Q2 2023

EPS Diluted

-$0.00

N/M vs Q2 2023

Gross Profit$48,656−35.5%

Operating Income

Same quarter

Metric	Q2 2024	Q2 2023	Q2 2012	Q2 2011
Revenue	$63.75K	$82.58K	$15.52M	$25.93M
Net Income	-$124.43K	-$219.89K	$1.81M	$4.88M
EPS Diluted	-$0.00	-$0.00	$0.13	$0.38

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Cannabis Bioscience International Holdings, Inc. · CIK 1411057 · Engraved from SEC EDGAR